
10/09/2025
Can the body’s own immune system become an ally in the fight against cancer? 🔬
In a recent Frontiers in Medicine publication, Dr. Brian Mehling and the Blue Horizon International research team explored the method of combining traditional chemotherapy with DC-CIK immunotherapy — a process that activates and reinfuses a patient’s own immune cells to better target cancer cells.
This research highlights the growing connection between cell therapy, regenerative medicine, and immunotherapy — and what it could mean for the future of personalized, cell-based care. 🌱
Read this article and Dr.Mehling’s previous studies on research gate or bluehorizoninternational.com 📍